SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,592.45 -318.56
( -0.39%)

Global Indices

Nasdaq

52,349.65 31.56
(0.06%)

Dow Jones

7,578.06 -35.34
(-0.46%)

Hang Seng

61,109.24 289.88
(0.48%)

Nikkei 225

10,906.25 43.16
(0.40%)

Forex

USD-INR

93.72 0.15
(0.16%)

EUR-INR

104.27 -0.51
(-0.49%)

GBP-INR

124.72 -0.66
(-0.52%)

JPY-INR

0.59 0.00
(-0.43%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aprameya Engineering Ltd

Industry : Healthcare

BSE Code

ISIN Demat

Book Value()

77825

INE0LQG01010

36.4170693

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

APRAMEYA

51.62

260.47

EPS(TTM)

Face Value()

Div & Yield %

2.65

Back

Symbiotec Pharmalab receives EIR report for Pithampur SEZ unit

Sep 29,2026

Symbiotec Pharmalab announced that it has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (U.S. FDA) for its manufacturing facility in Pithampur (SEZ), Madhya Pradesh India with a Voluntary Action Indicated (VAI) status. The inspection was conducted at the Company's manufacturing facility at Pithampur, from 10 August 2026 to 14 August 2026.

81,592.45 -318.56 ( -0.39%)

52,349.65 31.56 (0.06%)

7,578.06 -35.34 (-0.46%)

61,109.24 289.88 (0.48%)

10,906.25 43.16 (0.40%)

93.72 0.15 (0.16%)

104.27 -0.51 (-0.49%)

124.72 -0.66 (-0.52%)

0.59 0.00 (-0.43%)